CD4 and B-cell chronic lymphocytic leukemia: In contrast, in mice transplanted with cells of n=2 other CLL patients and receiving LDC526 treatment for 5 days we observed a rising CD4/CD8 ratio with increasing LDC526 doses (Figure 4B).